Biotech Startups

HIROTSUS Bioscience develops N-NOSE, a cancer screening test that uses nematodes to detect trace odor markers in urine samples, enabling early cancer detection. The company operates in medical diagnostics and contributes to public health through research and development.

1 investor

KORTUC develops a cancer radiotherapy (code name KRC-01) that uses hydrogen peroxide as a radiosensitizer to treat solid tumors. The company operates in the biopharmaceutical and radiation oncology space.

1 investor

Onodera develops AAV vector platforms for gene therapy research targeting neurological conditions. The company owns proprietary AAV vector patents, enabling internal development of therapeutic vectors without licensing costs from third parties.

1 investor

SiccaNova Therapeutics is a research-and-development-focused biotechnology company developing small-molecule drugs aimed at treating dryness-related medical conditions. Founded by drug-discovery and business-development specialists, it seeks to create new treatment options for patients with unmet medical needs.

1 investor

Taomics is a Japanese healthcare IT company that integrates omics testing with AI to build a digital twin of an individual's health status. It offers a platform for medical facilities and pharmaceutical/food companies to measure effectiveness and personalize treatments and product development, as well as consumer services for improving health and optimizing medical costs.

1 investor

TearExo develops a cancer detection method that analyzes exosomes in tears, aiming for a painless, non-invasive test to assess breast cancer risk and support early detection. Spun out of Kobe University in Japan, the company targets clinical screening as an alternative to blood-based and mammography testing.

1 investor

Trans Chromosomics develops drug-discovery technologies based on artificial chromosome engineering, including fully human antibody-producing mice and disease model animals for human and animal medicine. Its work supports therapeutic antibody development and related research applications.

1 investor

Vetanic develops regenerative medicine products and biologics for animals, starting with dogs, using its own animal iPS cell technology to produce donor-independent treatments such as canine mesenchymal stem cells (MSC). The company, based on joint research by Nihon University and Keio University, targets veterinarians and pet owners in Japan and is pursuing regulatory approval from the Ministry of Agriculture, Forestry and Fisheries.

1 investor

Waqoo is a Japanese company operating in regenerative medicine and consumer brand development, focused on health and wellness products and services. It is publicly listed on the Tokyo Stock Exchange Growth Market (securities code 4937).

1 investor

ARCS Inc. develops AI and robotics automation tools that help research laboratories standardize and streamline their operations. The company works with universities and businesses to build reliable, practical products for lab environments.

1 investor

iGene develops plasma-based molecular introduction technology for cellular engineering, enabling safe and efficient delivery of DNA and proteins into cells. The company targets applications in gene therapy, regenerative medicine, agriculture, and health/beauty sectors.

1 investor

Ecologgie produces specialized insect-based feed products for reptiles, including Leobait, a leopard gecko food made from 95% freeze-dried crickets. The company develops species-specific nutritional formulas in collaboration with Japanese universities.

1 investor

Oligogen is a Japanese biotech venture focused on regenerative medicine and drug discovery, conducting novel research and development in the pharmaceutical field.

1 investor

Space Bio-Laboratories develops regenerative medicine technologies and medical devices combining biotech with robotics, including gravity control systems for cell culture and walking assistance devices. The company targets incurable diseases like stroke, spinal cord injury, and myocardial infarction through advanced biotech research and rehabilitation solutions.

1 investor

Transgenic provides mice and related genetic research products, including frozen embryos, knockout mouse libraries, plasmid DNA products, and phenotype databases for academic and research institutions conducting basic life sciences research.

1 investor

Haplopharma provides genetic analysis services including contract genome sequencing, develops diagnostic instruments and test reagents, and conducts drug discovery research and development.

1 investor

euglena Co. develops products based on the microalgae euglena, which it was the first in the world to mass-cultivate outdoors for food use, applying it across health/food, biofuel, and nutrition initiatives. Founded to address malnutrition in Bangladesh, the company operates under a "Sustainability First" philosophy aimed at solving social and environmental problems.

1 investor

ReEir is a Japanese company founded out of regenerative medicine and wound-care expertise, working in areas such as regenerative medicine, wound surgery, and foot/podiatric care. It is led by academics and industry figures with backgrounds in plastic surgery, regenerative medicine, and medical devices.

1 investor

Retrieva is a Japanese company that develops generative AI and large language model technology, offering AI technical support (system building, engineer training, research support), AI products, and bio-AI solutions to businesses. Its offerings span AI consulting services and named products for enterprise and biotech applications.

1 investor

Revolka is a biotechnology company that uses its aiProtein technology — combining AI prediction with directed evolution and limited experimental data — to design high-performance proteins such as antibodies and enzymes. It serves pharmaceutical and biotech companies and research institutions, offering both in-house drug discovery and partnership-based protein development.

1 investor

Stem Cell & Device Laboratory (SCAD) commercializes pluripotent stem cell (ES/iPS) research from Kyoto University, developing cell and tissue products that combine stem cell technology with material and device technology. Its products are aimed at drug discovery assays and regenerative medicine, serving pharmaceutical and life science companies.

1 investor

Soiken Holdings is a biotech venture originating from Osaka University's medical faculty that develops and commercializes biomarker technologies and systems for objective health assessment across food, pharmaceutical, and healthcare applications.

1 investor

Bushu Pharma is a contract development and manufacturing organization (CDMO) that provides contract manufacturing of pharmaceutical products, with GMP certifications from major countries and exports to 56 nations. It serves pharmaceutical clients as a specialist in outsourced drug manufacturing for global markets.

1 investor

Jiichuan (Jumpcan) is a Chinese pharmaceutical and health company that develops and manufactures clinical medicines and everyday health products, including oral care solutions. It serves patients and general consumers seeking accessible treatment and daily wellness products.

1 investor